Archives: Speakers

Dr Morimoto has over 25 years of industry experience leading project teams in the development of innovative medicines for neurodegenerative diseases including Parkinson’s, Alzheimer’s, ALS and frontotemporal dementias.  Previously, Bruce held leadership roles at Alkahest, Celerion, Cerecin and Allon Therapeutics, and works closely with the Michael J Fox Foundation, chairing one of their scientific review panels.  He is an advisor to several biotech companies.  Bruce started his career on the faculty in the Chemistry Department at Purdue University.  Bruce earned his doctorate in biochemistry from UCLA and completed a postdoctoral fellowship at the University of California Berkeley.

Experienced Professional with a demonstrated history of working in the biotechnology industry. Skilled in Medical Devices, Biotechnology, Management, Cell Culture, and U.S. Food and Drug Administration (FDA). Strong healthcare services professional with a Masters of Science focused in Biological Science with an emphasis in Therapeutic Science and Pharmaceutical Business from Dominican University of California.

I was a corporate attorney with a marketing and sales background in highly-regulated industries (pharma/biotech). Regardless of industry or function, focus on client needs and delivering superlative business results are the hallmarks of my work. As an attorney in the Financial Services and Investment Management practice at Dechert LLP, I helped the boards and managers of various investment vehicles navigate complex compliance and business matters arising from operating in a dynamic regulatory environment. In my sales and marketing career in pharma/biotech, I developed business tools for reaching customers, built enduring and high-value customer relationships and delivered record-beating business results in a competitive market.

Innovative and Collaborative Compliance Leader with expertise and proven success in developing business strategy and establishing quality management framework for start-up compliance departments in large established pharmaceutical companies. -Healthcare Compliance, Rx&D Code of Ethical Practices and HCP value transfer -GCP compliance, auditing, regulatory inspection support, CAPA -Training (facillitation, instructional design, LMS management, curricula development) -Procedural Document Management (SOP creation, Documentum, Process Mapping)

• Passionate about advancing biomedical innovation to improve human health.
• VP Executive and Senior Leader within the biopharmaceutical industry.
• Driving global regulatory and development strategies for drug development (clinical products), marketing applications, and lifecycle management (marketed products).
• Proven success in bringing breakthrough therapies from development to approval:
• Rubraca® (rucaparib), for ovarian cancer with germline or somatic BRCA mutations diagnosed by a companion diagnostic.
• Voxzogo® (vosoritide), the first and only therapy approved for achondroplasia (rare disease), the most common form of dwarfism.
• Scientific foundation: Key inventor of two FDA approved drugs:
• Zelboraf® (Vemurafenib, the first personalized/precision medicine targeting melanoma).
• Prezista® (Darunavir, targeting HIV infection).
• Committed to making a difference through teamwork and science.

Alumis empowers innovative biomarker strategies under my leadership, where I oversee the full lifecycle of biospecimen management across clinical trials. With over three years at Alumis, I’ve spearheaded the creation of SOPs, directed biomarker sub-teams, and implemented multi-omics collection strategies to support autoimmune and immunology pipelines. Collaborative efforts with biomarker scientists, medical monitors, and bioinformaticians have driven operational success in translational and precision medicine initiatives. Over a decade of expertise in translational medicine and biospecimen operations underpins my commitment to advancing precision medicine. Past roles at Arcus Biosciences and Gilead Sciences honed my skills in clinical trial biosample management, biomarker planning, and vendor collaboration. My leadership fosters a culture of innovation and operational excellence, ensuring impactful contributions to clinical development and personalized healthcare solutions.

My career has been built on the belief that we achieve more when we come together. My purpose is to connect people and organizations through a robust Strategic Sourcing and Supplier Relationship Management approach. Leading, solving problems, building relationships, coaching, and bringing bold ideas to the table is what I do best.